BrainStorm Cell Therapeutics Inc. to Present at Several Scientific and Investment Conferences
4/10/2013 11:53:32 AM
More...
|
BrainStorm Cell Therapeutics Inc. Partners With Dana-Farber Cancer Institute for NurOwn™ Production in Phase II ALS Clinical Trial
4/8/2013 9:29:34 AM
More...
|
BrainStorm Cell Therapeutics Inc. Release: Results of NurOwn™ Clinical Trial Suggest Efficacy in ALS Patients
3/21/2013 9:56:41 AM
More...
|
Phase II ALS Clinical Trial With BrainStorm Cell Therapeutics Inc.'s NurOwn™ to be Expanded to a Third Premiere U.S. Clinical Site
3/18/2013 9:32:14 AM
More...
|
BrainStorm Cell Therapeutics Inc. Presents Breakthrough Phase I/II ALS Clinical Data at the American Academy of Neurology Annual Meeting
3/13/2013 8:30:18 AM
More...
|
BrainStorm Cell Therapeutics Inc. Presents at the 11th International Conference on Alzheimer's and Parkinson's Disease
3/11/2013 9:30:57 AM
More...
|
BrainStorm Cell Therapeutics Inc. to Present at the 8th Annual New York Stem Cell Summit
2/13/2013 6:59:20 AM
More...
|
BrainStorm Cell Therapeutics Inc. Announces Private Equity Financing of $250,000 With Individual Private Investor
2/11/2013 10:03:48 AM
More...
|
BrainStorm Cell Therapeutics Inc. Appoints Alon Natanson as CEO
1/28/2013 8:00:40 AM
More...
|
BrainStorm Cell Therapeutics Inc.’s CEO Issues Annual Letter to Shareholders
1/23/2013 9:26:46 AM
More...
|
|